$URGN 4 SEC Filings

Filed On	Filing
09 Oct 2026	Form 4: Degnan Chris, Chief Financial Officer Received 4,483 shares by exercise or conversion · Sold 2,202 shares ($80.8K)
09 Sep 2026	Form 4: Schoenberg Mark, Chief Medical Officer Received 1,667 shares by exercise or conversion · Sold 871 shares ($37.4K)
09 Sep 2026	Form 4: Smith Jason Drew, General Counsel Received 3,334 shares by exercise or conversion · Sold 1,519 shares ($64.6K)
28 Aug 2026	Form 4: Robinson James A. Jr., Director Received 2,000 shares by exercise or conversion
24 Aug 2026	Form 4: Schoenberg Mark, Chief Medical Officer Sold 60,677 shares ($2.85M)
10 Jul 2026	Form 4: Schoenberg Mark, Chief Medical Officer Sold 10,000 shares ($400K)
24 Jun 2026	Form 4: Schoenberg Mark, Chief Medical Officer Sold 10,000 shares ($350K)
24 Jun 2026	Form 4: Wildman Daniel George, Director Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit
24 Jun 2026	Form 4: Robinson James A. Jr., Director Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit
24 Jun 2026	Form 4: Holden Stuart, Director Granted 20,000 Stock Option (right ot buy)
24 Jun 2026	Form 4: Butitta Cynthia M, Director Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit
24 Jun 2026	Form 4: Wen Leana, Director Granted 10,000 Stock Option (right ot buy) · Granted 8,000 Restricted Stock Unit
24 Jun 2026	Form 4: Belldegrun Arie, Director Granted 20,000 Stock Option (right ot buy)
09 Jun 2026	Form 4: Schoenberg Mark, Chief Medical Officer Received 10,000 shares by exercise or conversion · Sold 5,222 shares ($143K)
27 May 2026	Form 4: Robinson James A. Jr., Director Received 2,000 shares by exercise or conversion
11 May 2026	Form 4: Schoenberg Mark, Chief Medical Officer Sold 10,000 shares ($300K)
27 Feb 2026	Form 4: Robinson James A. Jr., Director Received 2,000 shares by exercise or conversion
19 Feb 2026	Form 4: Barrett Elizabeth A., Chief Executive Officer Granted 153,195 Restricted Stock Units
11 Feb 2026	Form 4: Smith Jason Drew, General Counsel Received 15,500 shares by exercise or conversion · Granted 32,609 Restricted Stock Units · Sold 7,479 shares ($147K)
04 Feb 2026	Form 4: Schoenberg Mark, Chief Medical Officer Sold 7,373 shares ($145K)

Comments